By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) Release: OncoCyte Corporation’s Collaborators At The Wistar Institute Present Positive Clinical Interim Results Of Blood-Based Diagnostic Test For Non-Invasive Detection Of Lung Cancer 5/19/2015 1:15:03 PM
BioTime (BTX)'s Subsidiary Cell Cure Neurosciences Awarded $1.6 Million Grant From Israel’s Office Of The Chief Scientist 5/13/2015 8:19:58 AM
BioTime (BTX) Reports First Quarter 2015 Results And Recent Corporate Accomplishments 5/11/2015 11:54:14 AM
BioTime (BTX)’s Clinical Grade Stem Cells From Subsidiary ES Cell International To Be Used In Planned CIRM-Funded Preclinical Studies Of Huntington’s Disease 4/27/2015 8:35:07 AM
BioTime (BTX) Licenses Beckman Research Institute Of City of Hope To Manufacture Clinical Grade Stem Cells 4/22/2015 10:25:40 AM
BioTime (BTX) Reports Fourth Quarter and Fiscal Year End 2014 Financial Results and Recent Corporate Accomplishments 3/11/2015 10:29:43 AM
BioTime (BTX) Announces First Patient Treated In Pivotal Clinical Trial Of Renevia™ For HIV-Associated Lipoatrophy 2/24/2015 11:08:46 AM
ESI BIO – A Division Of BioTime (BTX), Announces Alliance Agreement With Pivotal Scientific For Distribution Of Stem Cell Products 2/23/2015 11:03:34 AM
ESI BIO – A Division Of BioTime (BTX) Announces New UK Distribution Agreement With 2BScientific 1/27/2015 10:16:41 AM
BioTime (BTX) Announces Issuance Of 14 New Patents In The Fields Of Regenerative Medicine, Stem Cell Technology, And Cancer Therapy 1/26/2015 8:35:01 AM